Malawi has administered all the Mpox vaccines it received from the United States government and the Global Alliance for Vaccines and Immunization (GAVI) as part of efforts to curb the spread of the disease.
This was disclosed on Thursday during a weekly press briefing by the Africa Centres for Disease Control and Prevention (Africa CDC).
Deputy Incident Manager from the Incident Management Support Team at Africa CDC, based out of the Democratic Republic of Congo, Professor Yap Boom, said Malawi administered 33,605 doses of the Mpox vaccine it received, achieving 100 percent utilisation.
He said the vaccines are part of a continent-wide campaign aimed at controlling the viral disease, which has affected several African countries in recent years.
Malawi’s Ministry of Health launched the Mpox vaccination campaign in October 2025, targeting high-risk groups such as healthcare workers and caregivers in 12 districts, including the epicentre Lilongwe and Blantyre.
Ministry of Health spokesperson Adrian Chikumbe said Mpox cases have drastically reduced in Malawi, with days passing without recording new confirmed infections.
Statistics from Africa CDC also show encouraging progress in the fight against cholera in Malawi. The country has recorded a 62 percent decline in cholera cases in recent weeks, placing Malawi among African countries experiencing decreasing transmission.
Chikumbe said Malawi is recording fewer cholera cases daily compared to the same period in previous years, attributing the improvement partly to the cholera vaccination campaign rolled out in most districts.
